Provided by Tiger Trade Technology Pte. Ltd.

Genprex, Inc.

2.56
-0.3600-12.33%
Post-market: 2.610.0500+1.95%19:35 EDT
Volume:142.14K
Turnover:383.70K
Market Cap:2.10M
PE:-0.01
High:2.98
Open:2.98
Low:2.53
Close:2.92
52wk High:1,210.00
52wk Low:2.53
Shares:819.70K
Float Shares:818.70K
Volume Ratio:0.58
T/O Rate:17.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-173.0075
EPS(LYR):-382.7870
ROE:-203.86%
ROA:-94.46%
PB:0.14
PE(LYR):-0.01

Loading ...

Genprex to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 08

Genprex selects manufacturing organization for diabetes gene therapy

TIPRANKS
·
Aug 18

Genprex Signs CDMO Deal to Scale up Manufacturing for Diabetes Gene Therapy Program

Reuters
·
Aug 18

Genprex - Continues to Optimize Constructs and Evaluate Alternative Delivery Approaches

THOMSON REUTERS
·
Aug 18

Genprex - CDMO to Manufacture Aav-Based Therapy for Preclinical Studies and Future Clinical Trials

THOMSON REUTERS
·
Aug 18

Genprex - Transfers Diabetes Product Manufacturing to Cgmp Compliant CDMO

THOMSON REUTERS
·
Aug 18

Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale up of Diabetes Gene Therapy

THOMSON REUTERS
·
Aug 18

Genprex Q2 Net Loss Narrows 5% to $4.45 Million Year over Year

Reuters
·
Aug 14

Genprex Must Keep NASDAQ Bid Price at or Above $1 Through Dec. 7 to Retain Listing

Reuters
·
Aug 06

Genprex Partners with Roche Diagnostics on NSCLC Biomarker Assay Validation Studies

Reuters
·
Aug 03

Genprex - Collaboration to Refine Patient Identification Using Trop2 Biomarker

THOMSON REUTERS
·
Aug 03

Genprex - Expects to Complete Validation Studies by End of 2026

THOMSON REUTERS
·
Aug 03

Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies

THOMSON REUTERS
·
Aug 03

Genprex trading halted, news pending

TIPRANKS
·
Jul 16

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Reuters
·
Jul 16

Genprex says CIPO issues Notice of Allowance for patent

TIPRANKS
·
Jun 22

Genprex wins Canadian patent allowance for Reqorsa combo with PD-1 or PD-L1 antibodies in lung cancer

Reuters
·
Jun 22

Genprex shareholders approve amended 2018 equity incentive plan at annual meeting

Reuters
·
Jun 19

Genprex participates in BIO International Convention 2026

Reuters
·
Jun 17

Genprex - Receives Nasdaq Notice of Non-Compliance With $1 Minimum Bid Price - SEC Filing

THOMSON REUTERS
·
Jun 13